Anika Therapeutics Inc (NASDAQ:ANIK)
| 28.10 Delayed Data As of Mar 24 |  +0.05 / +0.18%Today’s Change | 19.95 Today|||52-Week Range 32.51 | -5.07% Year-to-Date |
Latest ANIK News | Press Releases
| Anika Therapeutics (ANIK) Stock Sinks As Market Gains: What You Should Know Mar 20 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 28.05 |
| Today’s open | 27.52 |
| Day’s range | 27.52 - 28.10 |
| Volume | 2,796 |
| Average volume (3 months) | 93,135 |
| Market cap | $379.9M |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | -455.45% |
| Earnings growth (this year) | -14.71% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +5.71% |
| P/E ratio | NM |
| Price/Sales | 2.76 |
| Price/Book | 1.33 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MDXGMiMedx Group Inc | -0.14 | -3.95% |
| ---- | ||
| OSUROraSure Technologies... | +0.04 | +0.70% |
| TCMDTactile Systems Tech... | +0.62 | +3.90% |
Data as of 4:00pm ET, 03/24/2023
Financials
| Next reporting date | May 4, 2023 |
| EPS forecast (this quarter) | -$0.34 |
| Annual revenue (last year) | $156.2M |
| Annual profit (last year) | -$14.9M |
| Net profit margin | -9.51% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Bedford, Massachusetts |
Forecasts
